(Press-News.org) Contact information: Sheila Galloro
sgalloro@nmh.org
312-926-0735
Northwestern Memorial Hospital
First the hype, now the science: Evidence-based recommendations for PRP
CHICAGO – Platelet-rich plasma (PRP) has grabbed headlines in recent years for its role in helping some of sports' biggest stars return to play following injury –including golfer Tiger Woods, Super Bowl winner Hines Ward and NBA legend Kobe Bryant.
Professional and amateur athletes alike seek PRP to address a wide-range of orthopaedic conditions, including injuries to the joints, ligaments, tendons and muscles. PRP is made by placing a sample of a patient's own blood in a centrifuge to concentrate the platelets, which are cells rich in growth factors. The PRP is then injected back into the injury to stimulate tissue growth and healing.
Use of PRP has proliferated in recent years especially in sports medicine where injured athletes are eager to recover faster and return to their sport. Despite its rising popularity, PRP remains a costly treatment rarely covered by insurance because little scientific evidence has supported its use – until now.
A paper in the December issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) offers the first evidence-based recommendations for use of PRP in orthopaedic care. The authors, including two Northwestern Medicine® orthopaedic surgeons, determined which musculoskeletal conditions PRP is successful in treating and where more research is needed.
"The hype around PRP definitely came before the science," said Wellington Hsu, MD, the lead author on the paper, spine surgeon at Northwestern Memorial Hospital and assistant professor in orthopaedic surgery and neurological surgery at Northwestern University Feinberg School of Medicine. "In medicine, we rely on scientific evidence to support best use of treatments, but with PRP that hasn't been the case. Interest in PRP jumped way ahead of the research."
PRP does not involve any drugs or chemicals. "PRP is completely natural and uses the patient's own blood platelets to enhance the body's biological healing process," said Michael Terry, MD, co-author on the paper and an orthopaedic surgeon at Northwestern Memorial and associate professor of orthopaedic surgery at the Feinberg School. "There are very few documented complications associated with PRP; it's safe and has shown good results for many conditions."
The authors completed a comprehensive evaluation of published PRP research from around the world to develop their recommendations.
"While evidence suggests that that PRP improves tissue healing, we also found that success varies depending on the preparation method and composition of the PRP, medical condition, location on the body and tissue type," Hsu said.
The authors concluded that current evidence supports PRP as a treatment for conditions including arthritis in the ankle and tennis elbow (lateral epicondylitis) and that injecting PRP during ACL reconstruction contributes to healing. When it comes to using PRP for osteoarthritis of the knee, the authors were encouraged by early research, but recommended further study. They also suggested further study was needed in regards to Achilles tendon repair, rotator cuff injuries and other chronic tendinopathies aside from the elbow. PRP is not beneficial in bone healing applications and should not be used in spinal fusion or other bone grafting procedures, the authors concluded.
"We're hopeful that our findings can serve as a roadmap on how and when PRP is appropriate in orthopaedic care," said Terry. "Now that we have a better understanding of when this therapy is effective, we can tailor it to other applications. For example, if we know evidence supports PRP use for arthritic ankles and knees, it makes sense to start looking at it for osteoarthritis of the hip."
With scientific support now available, the costly treatment could eventually become more attainable for patients in the future.
"Insurers have not covered PRP because of the lack of science," said Hsu. "Patients currently pay out of pocket, sometimes thousands of dollars, to get PRP. With evidence-based recommendations, insurance companies hopefully will consider coverage for this therapy."
###
Northwestern's orthopaedics program is ranked first in Chicago and Illinois and seventh in the country on the U.S. News & World Report 2013-14 Best Hospitals specialty ranking for orthopaedics. For more information about orthopaedic care at Northwestern Memorial, visit our website or connect with us on social media.
To make an appointment with a Northwestern Medicine physician, call 312-926-0779.
About Northwestern Medicine®
Northwestern Medicine® is the collaboration between Northwestern Memorial HealthCare and Northwestern University Feinberg School of Medicine around a strategic vision to transform the future of healthcare. It encompasses the research, teaching and patient care activities of the academic medical center. Sharing a commitment to superior quality, academic excellence and patient safety, the organizations within Northwestern Medicine comprise more than 9,000 clinical and administrative staff, 3,100 medical and science faculty and 700 students. The entities involved in Northwestern Medicine remain separate organizations. Northwestern Medicine is a trademark of Northwestern Memorial HealthCare and is used by Northwestern University.
About Northwestern Memorial Hospital
Northwestern Memorial is one of the country's premier academic medical center hospitals and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Along with its Prentice Women's Hospital and Stone Institute of Psychiatry, the hospital has 1,705 affiliated physicians and 6,769 employees. Northwestern Memorial is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics.
Northwestern Memorial has nursing Magnet Status, the nation's highest recognition for patient care and nursing excellence. Northwestern Memorial ranks 6th in the nation in the U.S. News & World Report 2013-14 Honor Roll of America's Best Hospitals. The hospital is recognized in 14 of 16 clinical specialties rated by U.S. News and is No. 1 in Illinois and Chicago in U.S. News' 2013-14 state and metro rankings, respectively. For 14 years running, Northwestern Memorial has been rated among the "100 Best Companies for Working Mothers" guide by Working Mother magazine. The hospital is a recipient of the prestigious National Quality Health Care Award and has been chosen by Chicagoans as the Consumer Choice according to the National Research Corporation's annual survey for 15 consecutive years.
First the hype, now the science: Evidence-based recommendations for PRP
2013-12-10
ELSE PRESS RELEASES FROM THIS DATE:
Gut microbes affect MicroRNA response to bacterial infection
2013-12-10
Gut microbes affect MicroRNA response to bacterial infection
When it comes to fighting off pathogens like Listeria, your best allies may be the billions of microorganisms that line your gut, according to new research published in mBio®, the online open-access ...
Antibiotic-resistant typhoid likely to spread despite drug control program
2013-12-10
Antibiotic-resistant typhoid likely to spread despite drug control program
Restricting the use of antibiotics is unlikely to stop the spread of drug resistance in typhoid fever, according to a study funded by the Wellcome Trust and published in the journal eLife. ...
Money may corrupt, but thinking about time can strengthen morality
2013-12-10
Money may corrupt, but thinking about time can strengthen morality
Priming people to think about money makes them more likely to cheat, but priming them to think about time seems to strengthen their moral compass, according to new research ...
New study clarifies concerns regarding commonly used anti-nausea drug ondansetron
2013-12-09
New study clarifies concerns regarding commonly used anti-nausea drug ondansetron
For the past two years, warnings regarding the possible link between a commonly used anti-nausea and vomiting drug ondansetron and heart arrhythmias have been a source of uncertainty in emergency ...
From common colds to deadly lung diseases, 1 protein plays key role
2013-12-09
From common colds to deadly lung diseases, 1 protein plays key role
An international team of researchers has zeroed in on a protein that plays a key role in many lung-related ailments, from seasonal coughing and hacking to more serious diseases such as MRSA infections ...
Aging and gene expression -- possible links to autism and schizophrenia in offspring
2013-12-09
Aging and gene expression -- possible links to autism and schizophrenia in offspring
Advanced paternal age has been associated with greater risk for psychiatric disorders, such as schizophrenia and autism. With an increase in paternal age, there is a greater frequency ...
Optimal parameter of Neiguan acupuncture for cerebral infarction
2013-12-09
Optimal parameter of Neiguan acupuncture for cerebral infarction
The individual difference and non-repeatability in acupuncture have not only restricted the development of acupuncture, but have also affected the specificity of acupoints. As reported in a recent ...
rTMS for hallucination in schizophrenia spectrum disorders
2013-12-09
rTMS for hallucination in schizophrenia spectrum disorders
Repetitive transcranial magnetic stimulation uses a non-invasive and relatively painless tool to stimulate the human brain in vivo using very strong, pulsed magnetic fields. It is also used to explore and ...
Does zinc supplementation reduce aluminum-induced neurotoxicity?
2013-12-09
Does zinc supplementation reduce aluminum-induced neurotoxicity?
Studies have shown that aluminum neurotoxicity can likely affect learning and memory function, and a diet containing 100–200 mg/kg zinc is adequate for maintaining learning and memory function in ...
Prion protein can trigger spongiform encephalopathy and neurodegeneration
2013-12-09
Prion protein can trigger spongiform encephalopathy and neurodegeneration
Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein. Notably, C-transmembrane form of prion protein ...